Gustave Roussy Cancer Hospital recently received their second M3DIMAKER2 pharmaceutical 3D printer for use in their clinical pharmacy department. A press release from the hospital has highlighted how both 3D printers are now routinely being used to produce personalised medicines to treat the hospital’s cancer patients.
The M3DIMAKER2 is the second generation, GMP certified pharmaceutical 3D printer developed by the company FABRX where multiple printheads can be activated at the same time, resulting in high versatility of the technology. FABRX span out from the Basit Research Group in UCL School of Pharmacy and the group remains at the forefront of translating research on 3D printing of personalised medicines into real-world impact.
- Gustave Roussy Hospital
- FABRX
- Basit Research Group
- Basit Research Group LinkedIn
- Professor Abdul Basit (a.basit@ucl.ac.uk)
UCL GBSH Student Of The Week: Mohammed Alassaf
Mohammed, an MBA Health student and experienced health leader, is using his time at UCL to pivot from operations to the policy frameworks that define modern healthcare.
09 Mar 2026
Professor Sunita Sah to Teach on UCL Global Business School for Health's Executive MBA Health
UCL GBSH welcomes Professor Sunita Sah to teach leadership and decision‑making on the Executive MBA Health, bringing her clinical, academic and organisational expertise to the programme.
06 Mar 2026
DCAL Paid Internship Opportunities
Are you deaf and interested in language, psychology or neuroscience research? We offer paid Research Placement opportunities. Come and work with us!
05 Mar 2026